We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




DNA Replication Determines Cell Cycle Duration

By LabMedica International staff writers
Posted on 10 Jul 2018
An international team of cell and molecular biologists found that DNA damage and danger of cancer development were minimized by a molecular mechanism that delays cell division (mitosis) until two complete copies of the cell's genome are created.

To maintain genome stability, cells have to replicate their DNA before dividing. More...
Upon completion of bulk DNA synthesis, the mitotic kinases CDK1 and PLK1 become active and drive entry into mitosis.

Investigators at the Karolinska Institutet (Stockholm, Sweden) and the University of Sussex (United Kingdom) tested the hypothesis that DNA replication determined the timing of mitotic kinase activation. To do this, they generated a double-degron system to rapidly deplete the essential DNA replication-initiation factor CDC6 (Cell division control protein 6 homolog). A degron is a portion of a protein that is important in regulation of protein degradation rates. Known degrons include short amino acid sequences, structural motifs and exposed amino acids (often lysine or arginine) located anywhere in the protein. Some proteins contain multiple degrons.

The investigators reported in the June 28, 2018, online edition of the journal Molecular Cell that untransformed human cells shortened the cell cycle and prematurely entered mitosis in the absence of DNA replication. Using RNAi and inhibitors to independently target DNA replication licensing or firing, they found similar results in cancer cells. They also found that abrogating CHK1 activity in transformed cells, or CHK1 and p38 activity in untransformed cells enhanced CDK activation specifically upon G1/S transition, supporting the notion of a DNA replication checkpoint in human cells.

In the presence of DNA replication, inhibition of CHK1 and p38 led to premature activation of mitotic kinases, which induced severe replication stress. These results demonstrated that, rather than merely being a cell cycle output, DNA replication was an integral signaling component that restricted activation of mitotic kinases. DNA replication thus functioned as a brake that determined cell cycle duration.

"By creating cells that cannot copy their DNA and by following protein activities over time in single cells, we found that DNA replication blocks the enzymes that trigger cell division. Immediately after DNA replication is completed, the machinery that starts cell division is activated. This fundamental mechanism contributes to determining when human cells will divide," said senior author Dr. Arne Lindqvist, senior researcher in cell and molecular biology at Karolinska Institutet.

Related Links:
Karolinska Institutet
University of Sussex


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.